Failure of Erythromycin to Cure Secondary Syphilis in a Patient Infected With the Human Immunodeficiency Virus
- 1 January 1989
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 125 (1) , 82-84
- https://doi.org/10.1001/archderm.1989.01670130084011
Abstract
• The case presented here involves a 32-year-old homosexual man with human immunodeficiency virus seropositivity and secondary syphilis. Because of possible penicillin allergy, he was initially treated with erythromycin base by mouth. During four weeks of therapy, his cutaneous lesions worsened as did his systemic symptoms. Following desensitization and parenteral penicillin therapy, his cutaneous lesions and symptoms rapidly resolved. His VDRL titer fell appropriately. (Arch Dermatol 1989;125:82-84)This publication has 7 references indexed in Scilit:
- In vitro assay to demonstrate high-level erythromycin resistance of a clinical isolate of Treponema pallidumAntimicrobial Agents and Chemotherapy, 1988
- Alteration in the Natural History of Neurosyphilis by Concurrent Infection with the Human Immunodeficiency VirusNew England Journal of Medicine, 1987
- Syphilis in the AIDS EraNew England Journal of Medicine, 1987
- SYPHILIS IN HTLV-III INFECTED MALE HOMOSEXUALSAIDS Research, 1986
- Lymphocyte Transformation and the Effect of Circulating Immune Complexes in Humans with SyphilisSexually Transmitted Diseases, 1982
- Cell-mediated immunity during syphilis. A reviewSexually Transmitted Infections, 1978
- Failure of Erythromycin Estolate Therapy in In Utero SyphilisJAMA, 1964